-
Định danh
Số CAS
37248-47-8Công thức phân tử
C20H35NO13SMILES
C1[C@@H]([C@H]([C@@H]([C@H]([C@H]1N[C@H]2C=C([C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO
Nhãn an toàn
Kích ứng -
Hồ sơ mùi hương
Không mùi 74.06% Ngọt 41.11% Cồn 21.66% Thơm ngon 17.83% Mát lạnh 17.64% Tanh cá 16.61% Gỗ 16.32% Caramel 16.14% Đắng 16.06% Vani 15.7% Scent© AI
-
Thuộc tính
XLogP3-AA
-6.3Khối lượng phân tử
497.5 g/molÁp suất hơi ước lượng
- hPa @ 20°C
- hPa @ 25°C
Tốc độ bay hơi
Tương đối nhanhNhiệt độ sôi ước lượng
3906°CNhiệt độ tan chảy thực nghiệm
- 130-135 °C (with decomp)
Nhiệt độ chớp cháy ước lượng
312.97 ˚CĐộ tan thực nghiệm
- Solubility: very soluble in water; soluble in dimethylformamide, dimethyl sulphoxide, methanol; sparingly soluble in acetone, ethanol.
- Sparingly soluble in diethyl ether and ethyl acetate.
-
Các tên gọi
- Validamycin
- VALIDAMYCIN A
- 37248-47-8
- Validacin
- Valimon
- UNII-313E9620QS
- CHEBI:29703
- HSDB 6745
- 313E9620QS
- T-7545-A
- VALIDAMYCIN A [HSDB]
- (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- DTXSID4058073
- VALIDAMYCINS VALIDAMYCIN A [MI]
- (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-d-chiro-inositol
- (1S-(1alpha,4alpha,5beta,6alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
- 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside
- 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside
- D-1,5,6-Trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
- (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside
- (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1-alpha,4-alpha,5-beta,6-alpha))-
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1.ALPHA.,4.ALPHA.,5.BETA.,6.ALPHA.))-
- Validamycin A (>70%) Hydrochloride Salt
- Cepex 10SL; Validacin
- Validamycin A Sulfate salt (Technical grade)
- jinganmycin A
- (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl beta-D-glucopyranoside
- (2R,3R,4S,5S,6R)-2-((1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexoxy)-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2R,5S)-2-((1R,2R,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,5S)-2-[(1R,2R,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
- 1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
- 1,5,6-Trideoxy-4-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
- 1,5,6-Trideoxy-4-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
- D-chiro-Inositol, 1,5,6-trideoxy-4-O-.beta.-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-BETA-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-
- D-chiro-Inositol, 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
- MFCD09028089
- (+)-validamycin A
- Validamycin A (Standard)
- SCHEMBL3121491
- CHEMBL1923413
- DTXCID0031841
- HY-B0856R
- VALIDAMYCINS VALIDAMYCIN A
- JARYYMUOCXVXNK-CSLFJTBJSA-N
- HY-B0856
- T7545A
- AKOS016012982
- AG-F-30599
- AV59477
- AC-32607
- AS-15281
- CS-0012869
- Validamycin A, PESTANAL(R), analytical standard
- Validamycin; CE30; JARYYMUOCXVXNK-CSLFJTBJSA-N
- D-Chiro-inositol,1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-
- (1S(1a,4a,5b,6a))1,5,6Trideoxy3ObDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol
- (1S(1alpha,4alpha,5beta,6alpha))1,5,6trideoxy4ObetaDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol
- (1S-(1 alpha, 4 alpha, 5 beta, 6 alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
- (1S-(1.ALPHA.,4.ALPHA.,5.BETA.,6.ALPHA.))-1,5,6-TRIDEOXY-4-O-.BETA.-D- GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3- (HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-D-CHIRO-INOSITOL
- (1S-(1A,4A,5B,6A))-1,5,6-TRIDEOXY-3-O-B-D-GLUCOPYRANOSYL-5- (HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-D-CHIRO-INOSITOL
- (1S-(1a,4a,5B,6a))-1,5,6-trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-=2-cyclohexen-1-yl)amino)-d-chiro-inositol
- (1S-(1a,4a,5b,6a))-1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
- (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
- 1L(1,3,4/2,6)2,3Dihydroxy6hydromethyl4((1S,4R,5S,6S)4,5,6trihydroxy3hydroxymethylcyclohex2enylamino)cyclohexyl betaDglucopyranoside
- 1L(1,3,4/2,6)2,3Dihydroxy6hydroxymethyl4((1S,4R,5S,6S)4,5,6trihydroxy3hydroxymethylcyclohex2enylamino)cyclohexyl betaDglucopyranoside
- 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROMETHYL-4-((1S,4R,5S,6S)- 4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2- ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
- 1L-(1,3,4/2,6)-2,3-dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino) cyclohexyl beta-D-glucopyranoside
- 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROMETHYL-4-((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2-ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
- 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROXYMETHYL-4- ((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2- ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
- 1l-(1,3,4/2,6)-2,3-dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl I2-D-glucopyranoside
- 58194-43-7
- 609-372-4
- D-1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL-5- (HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-D-CHIROINOSITOL
- D-1,5,6-Trideoxy-3-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
- D-1,5,6-Trideoxy-3-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL- 5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-, (1S-(1-.ALPHA.,4-.ALPHA.,5-.BETA.,6- .ALPHA.))-
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1-.ALPHA.,4-.ALPHA.,5-.BETA.,6-.ALPHA.))-
- D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-BETA-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1ALPHA,4ALPHA,5BETA,6ALPHA))-
- D1,5,6Trideoxy3ObetaDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol
-
Độ tan @25˚C
Dung môi Độ tan (g/L) ethanol 1.41 methanol 4.1 isopropanol 0.25 water 44.19 ethyl acetate 0.13 n-propanol 0.44 acetone 0.4 n-butanol 0.3 acetonitrile 0.15 DMF 7.1 toluene 0.08 isobutanol 0.12 1,4-dioxane 0.92 methyl acetate 0.11 THF 0.9 2-butanone 0.21 n-pentanol 0.12 sec-butanol 0.16 n-hexane 0.01 ethylene glycol 11.93 NMP 12.02 cyclohexane 0.05 DMSO 41.08 n-butyl acetate 0.05 n-octanol 0.14 chloroform 0.04 n-propyl acetate 0.04 acetic acid 7.67 dichloromethane 0.05 cyclohexanone 0.55 propylene glycol 4.93 isopropyl acetate 0.08 DMAc 6.28 2-ethoxyethanol 2.2 isopentanol 0.11 n-heptane 0.04 ethyl formate 0.22 1,2-dichloroethane 0.06 n-hexanol 0.15 2-methoxyethanol 9.36 isobutyl acetate 0.02 tetrachloromethane 0.02 n-pentyl acetate 0.1 transcutol 3.82 n-heptanol 0.23 ethylbenzene 0.03 MIBK 0.09 2-propoxyethanol 1.61 tert-butanol 0.11 MTBE 0.04 2-butoxyethanol 1.33 propionic acid 0.73 o-xylene 0.08 formic acid 68.14 diethyl ether 0.13 m-xylene 0.07 p-xylene 0.02 chlorobenzene 0.02 dimethyl carbonate 0.61 n-octane 0.02 formamide 38.71 cyclopentanone 0.91 2-pentanone 0.22 anisole 0.06 cyclopentyl methyl ether 0.39 gamma-butyrolactone 1.09 1-methoxy-2-propanol 3.54 pyridine 0.49 3-pentanone 0.19 furfural 1.96 n-dodecane 0.01 diethylene glycol 6.1 diisopropyl ether 0.03 tert-amyl alcohol 0.11 acetylacetone 0.52 n-hexadecane 0.01 acetophenone 0.14 methyl propionate 0.32 isopentyl acetate 0.03 trichloroethylene 0.09 n-nonanol 0.15 cyclohexanol 0.34 benzyl alcohol 0.22 2-ethylhexanol 0.06 isooctanol 0.11 dipropyl ether 0.13 1,2-dichlorobenzene 0.02 ethyl lactate 0.31 propylene carbonate 0.31 n-methylformamide 3.99 2-pentanol 0.13 n-pentane 0.02 1-propoxy-2-propanol 0.74 1-methoxy-2-propyl acetate 0.32 2-(2-methoxypropoxy) propanol 0.75 mesitylene 0.04 ε-caprolactone 0.54 p-cymene 0.03 epichlorohydrin 0.54 1,1,1-trichloroethane 0.01 2-aminoethanol 7.11 morpholine-4-carbaldehyde 9.11 sulfolane 6.24 2,2,4-trimethylpentane 0.01 2-methyltetrahydrofuran 0.26 n-hexyl acetate 0.1 isooctane 0.0 2-(2-butoxyethoxy)ethanol 1.66 sec-butyl acetate 0.03 tert-butyl acetate 0.08 decalin 0.01 glycerin 27.8 diglyme 2.4 acrylic acid 1.93 isopropyl myristate 0.03 n-butyric acid 0.56 acetyl acetate 0.15 di(2-ethylhexyl) phthalate 0.08 ethyl propionate 0.07 nitromethane 3.95 1,2-diethoxyethane 0.23 benzonitrile 0.06 trioctyl phosphate 0.07 1-bromopropane 0.03 gamma-valerolactone 3.63 n-decanol 0.1 triethyl phosphate 0.07 4-methyl-2-pentanol 0.05 propionitrile 0.06 vinylene carbonate 0.35 1,1,2-trichlorotrifluoroethane 3.51 DMS 0.16 cumene 0.02 2-octanol 0.1 2-hexanone 0.06 octyl acetate 0.07 limonene 0.05 1,2-dimethoxyethane 0.88 ethyl orthosilicate 0.07 tributyl phosphate 0.05 diacetone alcohol 0.59 N,N-dimethylaniline 0.1 acrylonitrile 0.17 aniline 0.27 1,3-propanediol 4.75 bromobenzene 0.01 dibromomethane 0.03 1,1,2,2-tetrachloroethane 0.1 2-methyl-cyclohexyl acetate 0.05 tetrabutyl urea 0.14 diisobutyl methanol 0.04 2-phenylethanol 0.17 styrene 0.03 dioctyl adipate 0.07 dimethyl sulfate 2.08 ethyl butyrate 0.06 methyl lactate 2.21 butyl lactate 0.3 diethyl carbonate 0.04 propanediol butyl ether 1.83 triethyl orthoformate 0.09 p-tert-butyltoluene 0.03 methyl 4-tert-butylbenzoate 0.34 morpholine 1.67 tert-butylamine 0.04 n-dodecanol 0.07 dimethoxymethane 2.28 ethylene carbonate 0.23 cyrene 2.07 2-ethoxyethyl acetate 0.27 2-ethylhexyl acetate 0.03 1,2,4-trichlorobenzene 0.03 4-methylpyridine 0.2 dibutyl ether 0.06 2,6-dimethyl-4-heptanol 0.04 DEF 0.91 dimethyl isosorbide 1.12 tetrachloroethylene 0.14 eugenol 0.48 triacetin 0.27 span 80 0.96 1,4-butanediol 1.13 1,1-dichloroethane 0.02 2-methyl-1-pentanol 0.06 methyl formate 2.02 2-methyl-1-butanol 0.13 n-decane 0.02 butyronitrile 0.06 3,7-dimethyl-1-octanol 0.05 1-chlorooctane 0.04 1-chlorotetradecane 0.01 n-nonane 0.02 undecane 0.01 tert-butylcyclohexane 0.0 cyclooctane 0.04 cyclopentanol 0.43 tetrahydropyran 0.3 tert-amyl methyl ether 0.07 2,5,8-trioxanonane 2.0 1-hexene 0.02 2-isopropoxyethanol 0.62 2,2,2-trifluoroethanol 4.18 methyl butyrate 0.09 Scent© AI
| Nồng độ tối đa được chấp nhận trong sản phẩm hoàn thiện (%) | |||
|---|---|---|---|
|
Danh mục 1
Sản phẩm sử dụng cho môi
|
Không hạn chế |
Danh mục 7A
Sản phẩm rửa xả thoa lên tóc có tiếp xúc với tay
|
Không hạn chế |
|
Danh mục 2
Sản phẩm sử dụng cho vùng nách
|
Không hạn chế |
Danh mục 7B
Sản phẩm lưu lại trên tóc có tiếp xúc với tay
|
Không hạn chế |
|
Danh mục 3
Sản phẩm thoa lên mặt/cơ thể bằng đầu ngón tay
|
Không hạn chế |
Danh mục 8
Sản phẩm có tiếp xúc đáng kể với vùng hậu môn - sinh dục
|
Không hạn chế |
|
Danh mục 4
Sản phẩm liên quan đến nước hoa
|
Không hạn chế |
Danh mục 9
Sản phẩm tiếp xúc với cơ thể và tay, chủ yếu rửa xả
|
Không hạn chế |
|
Danh mục 5A
Sản phẩm dưỡng thể thoa lên cơ thể bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
|
Không hạn chế |
Danh mục 10A
Sản phẩm chăm sóc nhà cửa chủ yếu tiếp xúc với tay
|
Không hạn chế |
|
Danh mục 5B
Sản phẩm dưỡng ẩm cho mặt thoa lên mặt bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
|
Không hạn chế |
Danh mục 10B
Sản phẩm chăm sóc nhà cửa chủ yếu tiếp xúc với tay, bao gồm dạng xịt/phun (có khả năng lưu lại trên da)
|
Không hạn chế |
|
Danh mục 5C
Kem dưỡng da tay thoa lên tay bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
|
Không hạn chế |
Danh mục 11A
Sản phẩm dự kiến tiếp xúc với da nhưng hầu như không truyền hương lên da từ chất nền trơ, không tiếp xúc với tia UV
|
Không hạn chế |
|
Danh mục 5D
Kem dưỡng, dầu dưỡng và phấn rôm cho em bé
|
Không hạn chế |
Danh mục 11B
Sản phẩm dự kiến tiếp xúc với da nhưng hầu như không truyền hương lên da từ chất nền trơ, có khả năng tiếp xúc với tia UV
|
Không hạn chế |
|
Danh mục 6
Sản phẩm tiếp xúc với miệng và môi
|
Không hạn chế |
Danh mục 12
Sản phẩm không nhằm tiếp xúc trực tiếp với da, chỉ truyền rất ít hoặc không đáng kể sang da
|
Không hạn chế |